Get started
Author

Gillian O’Hurley

Garbage in, garbage out: A critical evaluation of strategies used for validation of immunohistochemical biomarkers
2014 · Gillian O'Hurley, Evelina Sjöstedt, et al. · Molecular Oncology · 181
PDF
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer
2016 · Magali Michaut, Suet-Feung Chin, et al. · Scientific Reports · 169
PDF
Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer
2017 · Bo Li, Triona Ni Chonghaile, et al. · Cancer Research · 96
Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model
2013 · Frida Danielsson, Marie Skogs, et al. · Proceedings of the National Academy of Sciences · 62
PDF
Ensemble based system for whole-slide prostate cancer probability mapping using color texture features
2011 · Matthew D. DiFranco, Gillian O’Hurley, et al. · Computerized Medical Imaging and Graphics · 60
Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer
2012 · Antoinette S. Perry, Gillian O'Hurley, et al. · International Journal of Cancer · 44
Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer
2015 · Gillian O'Hurley, Christer Busch, et al. · PLoS ONE · 29
PDF
The role of secreted frizzled-related protein 2 expression in prostate cancer
2011 · Gillian O’Hurley, Antoinette S Perry, et al. · Histopathology · 29
Carbonic anhydrase IX expression in prostate cancer
2009 · L G Smyth, G O'Hurley, et al. · Prostate Cancer and Prostatic Diseases · 28
Investigation of molecular alterations of AKT ‐3 in triple‐negative breast cancer
2013 · Gillian O'Hurley, Etáin Daly, et al. · Histopathology · 24
Identification of transcription factors associated with castration‐resistance: Is the serum responsive factor a potential therapeutic target?
2013 · Maria Prencipe, Stephen F. Madden, et al. · The Prostate · 18
The analysis of serum response factor expression in bone and soft tissue prostate cancer metastases
2013 · Gillian O'Hurley, Maria Prencipe, et al. · The Prostate · 14
PDF
Analysis of plasma from prostate cancer patients links decreased carnosine dipeptidase 1 levels to lymph node metastasis
2013 · Ulrika Qundos, Henrik Johannesson, et al. · Translational Proteomics · 10
PDF
Relationship between serum response factor and androgen receptor in prostate cancer
2015 · Maria Prencipe, Amanda O'Neill, et al. · The Prostate · 9
Evaluation of Zinc-α-2-Glycoprotein and Proteasome Subunit β-Type 6 Expression in Prostate Cancer Using Tissue Microarray Technology
2010 · Gillian O'Hurley, Anthony O'Grady, et al. · Applied immunohistochemistry & molecular morphology · 9
Abstract PD3-01: CDK7: A marker of poor prognosis and tractable therapeutic target in triple-negative breast cancer
2016 · WM Gallagher, B Li, et al. · Cancer Research · 1
545 DHT Regulates Serum Response Factor Transcription Activity in Castrate-resistant Prostate Cancer Cell Lines
2012 · M. Prencipe, A. O'Neill, et al. · European Journal of Cancer · 1
Data from Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer
2023 · Bo Li, Triona Ni Chonghaile, et al.
Figure S5 from Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer
2023 · Bo Li, Triona Ni Chonghaile, et al.
Figure S1 from Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer
2023 · Bo Li, Triona Ni Chonghaile, et al.
Supplementary Figure Legends from Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer
2023 · Bo Li, Triona Ni Chonghaile, et al.
Figure S2 from Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer
2023 · Bo Li, Triona Ni Chonghaile, et al.
Figure S3 from Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer
2023 · Bo Li, Triona Ni Chonghaile, et al.
Figure S5 from Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer
2023 · Bo Li, Triona Ni Chonghaile, et al.
Figure S2 from Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer
2023 · Bo Li, Triona Ni Chonghaile, et al.
Works count: 35
Citation count: 784
H-index: 12
I10-index: 13
Year
Topic
Type